Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Long-acting GLP-1R agonist as a therapy of neurological and neurodegenerative conditions

Long-acting GLP-1R agonist as a therapy of neurological and neurodegenerative conditions

US Patent 11123405 · Granted Sep 21, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Gate driving circuit and display device including gate driving circuit2025
Detection of PAR in the CSF of patients with Parkinson's disease2025
Detection of PAR in the CSF of patients with Parkinson's disease2025
Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative co2025
Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative co2025
Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative co2025
Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative co2025
Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative co2025
Long-acting GLP-1r agonist as a therapy of neurological and neurodegenerative co2025
System and method for electrical impedance tomography of an object, and an imped2024
Implantable sensor electronics packaging2023
Trail compositions with reduced immunogenicity2023